SEARCH RESULTS FOR:

Mining
Canada

Michael Gignac

VICE PRESIDENT, FINANCE, G MINING SERVICES
G Mining Services is enjoying strong demand for its services while also looking to own its own precious metals projects.
Mining
Canada

A. Paul Gill

CEO, LOMIKO METALS INC.
Lomiko Metals speaks to GBR about its’ La Loutre graphite project in Québec.
Petrochemicals & Chemicals
Singapore

Singapore Chemicals 2021

Italy
Pharma & Life Sciences

Salvatore Butti

PRESIDENT, ASSOSALUTE - FEDERCHIMICA
Assosalute represents non-prescription medical products in Italy and explains how easing regulations could be of huge benefit to Italians and the healthcare system.
Mining
Canada

Paul Carmel

PRESIDENT & CEO, SIDEX
SIDEX explains how it provides financial stimulus to the exploration sector of the Québec mining industry.
United States
Pharma & Life Sciences

Dr. Siva Samy

CEO & CHIEF PRODUCT STRATEGIST, VALGENESIS
United States Pharmaceuticals & Biopharmaceuticals 2021 - Digital Interactive
ValGenesis explains how it streamlines the validation process to allow real-time access to validation documents and data enabling various stakeholders to achieve compliance efficiently.
United States
Pharma & Life Sciences

Michael Kauffman

CEO, KARYOPHARM THERAPEUTICS
United States Pharmaceuticals & Biopharmaceuticals 2021 - Digital Interactive
GBR speaks to Karyopharm Therapeutics about the commercialization of XPOVIO.
Petrochemicals & Chemicals
Singapore

Raymond Sinnah

PRESIDENT OF MINERAL SPECIALTIES DIVISION, SEQENS GROUP
Seqens group in Singapore explains on going expansion.
Petrochemicals & Chemicals
Singapore

Chye Poh Chua

FOUNDER AND CEO, SHIPSFOCUS GROUP
ShipsFocus Group explains why the shipping industry is ripe for a digital revolution and how Singapore’s start-ups are preparing.
Mining
Peru

Fernando Barrio

GENERAL MANAGER, TECNOMINA
Tecnomina in Peru explains how it managed to achieve a bit of growth during a difficult year.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL